P3 Health Partners (PIII) EBIT (2021 - 2025)

P3 Health Partners (PIII) has reported EBIT for 5 consecutive years, with -$153.9 million the latest figure, recorded in Q4 2025.

• EBIT for Q4 2025 came in at -$153.9 million, down 11.09% year-over-year; the trailing twelve-month figure through Dec 2025 was -$270.3 million (up 15.7% YoY), and the FY2025 annual result was -$270.3 million, up 15.7% from the prior year.
• EBIT was -$153.9 million for Q4 2025 at P3 Health Partners, down from -$44.2 million in the prior quarter.
• Over five years, EBIT peaked at $564.4 million in Q4 2021 and troughed at -$912.2 million in Q2 2022.
• Average EBIT over 5 years is -$91.1 million, with a median of -$44.0 million recorded in 2024.
• Year-over-year, EBIT slumped 3412.32% in 2022 and surged 97.69% in 2023.
• Over 5 years, EBIT stood at $564.4 million in 2021, then plunged by 195.07% to -$536.5 million in 2022, then jumped by 88.02% to -$64.3 million in 2023, then sank by 115.54% to -$138.5 million in 2024, then decreased by 11.09% to -$153.9 million in 2025.
• Per Business Quant data, the three most recent EBIT figures were -$153.9 million in Q4 2025, -$44.2 million in Q3 2025, and -$34.1 million in Q2 2025.